INVA
Innoviva, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q3 2026: 21 added (0 new), 20 trimmed or exited.
- AnalystsBULLISH
9 of 11 rate it Buy or better. Median target $34.00 (+84%).
- EstimatesFALLING
Current-quarter EPS estimate $0.572 → $0.446 over 90 days. 1 up, 1 down in 30 days.
- Short sellersSTEADY
Short interest +3.2% to 7.50M shares. 12.9 days to cover, ≈10.5% of shares.
- TrendDOWNTREND
10% below its 50-day average. New closing low $18.49 on Nov 16.
- SocialQUIET
No Reddit mentions this week. Last mention Oct 21.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| MORGAN STANLEY | ADD | $36.5M |
| Qube Research & Technologies Ltd | ADD | $25.8M |
| Invesco Ltd. | ADD | $25.1M |
| UBS Group AG | ADD | $22.2M |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | ADD | $17.7M |
| AMERICAN CENTURY COMPANIES INC | TRIM | $16.0M |
| MARSHALL WACE, LLP | TRIM | $13.4M |
| Empowered Funds, LLC | ADD | $8.9M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
11 analystsPrice is inside the target range. Median implies +84%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 5, 2026 | Oppenheimer MAINTAIN | Outperform |
| Aug 7, 2026 | Cantor Fitzgerald MAINTAIN | Overweight |
| Jun 22, 2026 | BTIG MAINTAIN | Buy |
| Jun 1, 2026 | HC Wainwright & Co. REITERATE | Buy |
| May 26, 2026 | BTIG REITERATE | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Raifeld Pavel Chief Executive Officer Aug 20, 2026 | TAX W/H | $23.7K |
Basso Stephen Chief Financial Officer Aug 20, 2026 | TAX W/H | $11.7K |
Zhen Marianne Chief Accounting Officer Aug 20, 2026 | TAX W/H | $23.7K |
Raifeld Pavel Chief Executive Officer May 20, 2026 | TAX W/H | $25.1K |
Zhen Marianne Chief Accounting Officer May 20, 2026 | TAX W/H | $25.1K |
Basso Stephen Chief Financial Officer May 20, 2026 | TAX W/H | $12.4K |
Linden Josephine Director May 18, 2026 | AWARD | 5,733 sh |
Linden Josephine Director May 18, 2026 | AWARD | 9,166 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.45 | $0.35–$0.53 | -14.6% | $110.8M |
| Next Q | $0.49 | $0.41–$0.55 | -1.2% | $113.1M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | $2.14 | $1.87–$2.35 | -5.3% | $475.3M |
Short side
FINRA· Oct 30, 2026SecBot reports
5 filings · 0 bullish · 1 bearish · 2 mixed · 2 neutral- BEARISH 8-KNov 4, 2026
Innoviva Q3 2026 total revenue of $106.1M declined 1.6% YoY, missing the $115.3M consensus, as…
The revenue miss and GAAP net loss driven by investment mark-to-market are the headline negatives, but operating income grew 22% and IST product sales accelerated 45% YoY. Watch for Q4 revenue…
- MIXED INST-CLUSTEROct 27, 2026
Institutional activity in Innoviva (INVA) during 2026-Q2 shows a mixed picture: 24 buyers added…
The heavy selling by active managers (Arrowstreet, Man Group, Barclays) contrasts with smaller buys from passive and smaller asset managers. Monitor next 13F for further reduction or stabilization…
- NEUTRAL 8-KMay 18, 2026
Innoviva reported the resignations of board members Derek Small and Mark DiPaolo to focus on their…
Routine board refresh with no financial or strategic implications. No trading catalyst. Monitor for any future disclosures on Innoviva's investment trajectory in Syndeio BioSciences, but this filing…
- MIXED 8-KMay 6, 2026
Innoviva reported Q1 2026 total revenue of $98.0M (+11% YoY, slightly below $101.6M consensus) and…
The massive EPS beat is entirely from volatile investment portfolio gains (Armata), which are not recurring. Revenue miss and operating income decline signal underlying softness in the core royalty…
All INVA filing & press-release reports (5)
- 8-K reportNov 4, 2026
- INST-CLUSTER reportOct 27, 2026
- 8-K reportMay 18, 2026
- 8-K reportMay 6, 2026
- 10-K/A reportMar 27, 2026